Navigation Links
The Myxo File Part III, Biographical story of a Cardiologist requesting help from the President, Barack H. Obama, for her patients in Chicago
Date:1/29/2013

CHICAGO, Jan. 29, 2013 /PRNewswire/ --The Myxo File: Part III, Published January 24, 2013, just released through Kindle Direct Publishing, will provide documents from the FDA, SEC and the U.S. patent office action to further understand the issues that go into heart device manufacturing and safety issues in U.S. patients. A providential meeting with the President of the United States on his birthday in Chicago, with the author and her mother, will turn the events for the patients going to open-heart surgery in the U.S.A. forever.

(Photo:  http://photos.prnewswire.com/prnh/20130129/CG48860 )

"The patients need to understand this process and the Myxo File Part III provides a step-by-step chart for a patient to ask the important questions prior to going for open heart surgery,"  says author Nalini Marie Rajamannan M.D. of Sacred Heart Cardiology, Chicago IL.

"My book will help to educate the citizens of the United States of America and globally to ask the important questions prior to open heart surgery as to whether the device that will be used to repair their valve is FDA registered, cleared, approved, investigational or none of the above," says Dr. Rajamannan.

Rajamannan was inspired to create the Myxo File when the documents she accumulated over a five-year quest to get the information regarding the patients ended with a search of the U.S. SEC website. The filings indicate the chronology of disclosures of the medical device to investors. "With my electronic file and 3-Agency Chart, you still have to take action, and ask your physicians whether you are about to be included in a clinical study to test devices prior to FDA clearance, but at least the citizens of the United States will have a guidepost to help them ask the right questions.

Nalini M. Rajamannan is a cardiologist at Sacred Heart Cardiology, Sheboygan, WI, and Chicago, IL. She is the CEO of ConcieValve LLC, and recently published her textbook on Cardiac Valvular Medicine, Springer Publisher. She graduated from the University of Notre Dame, South Bend IN and Mayo Medical School and Mayo Graduate School, Rochester MN for all of her medical training. She is the chair of the recently published position statement from the NHLBI, NIH working group on Calcific Aortic Valve Disease. Dr. Rajamannan has published an International Clinical trial on the effects of statins in slowing the progression of aortic valve disease in the Journal of the American College of Cardiology with her colleagues from Spain and Portugal.


'/>"/>
SOURCE Nalini Rajamannan, MD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Arthritis Associates of South Florida Acquires Access to Patient Health History Faster with Digital Pen Technology from Anoto and NextGen Healthcare
2. Medical Marijuana Inc.s Subsidiary, PhytoSPHERE Systems, Signs the Largest Production Contract in Company History Valued at $7.5 Million
3. Shield HealthCare Announces 12th Annual Caregiver Story Contest
4. Producer Austin Chapman Reaches Millions with Inspiring Story on Hearing Loss; Launches Contest in Partnership with Phonak
5. Star Scientific, Inc. Refutes Story Published on TheStreet.com
6. Arbor Pharmaceuticals partners with the Association of Black Cardiologists to further the campaign of "Saving Hearts of a Diverse America"
7. Top New York City Cardiologist Dr. Steven Reisman to be Featured on Inside Edition to Discuss Mini-Strokes and Strokes
8. Leading Cardiologist Dispels the Myths about Dietary Supplement Niacin
9. Watson Names Lisa DeFrancesco Vice President, Global Investor Relations
10. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
11. Merz, Inc. Announces Promotion of Katrina Church to Vice President, Chief Compliance Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
(Date:4/28/2016)... , April 28, 2016 ... Review, H1 2016" is a report that provides ... helps strengthen R&D pipelines by identifying new targets ... Company Profiles discussed in this H1 ... Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., ...
(Date:4/27/2016)... 27, 2016   ... in Recurring Consumable Sales  Clinical sales grow ... Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the ... for the first quarter ended March 31, 2016 and ... of its commercial strategy. First Quarter 2016 ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... ... team BioCellection won the $30,000 Perlman Grand Prize of the 2016 Wharton Business ... Award, the Michelson People’s Choice Award, and the Committee Award for Most ‘Wow ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... Canadian Celiac Association (CCA), is pleased to announce the launch of the ... nutritional articles, recipes, and more. The purpose of the GFCP Scoop ...
(Date:4/29/2016)... ... April 29, 2016 , ... New York City based oral and maxillofacial surgeon Dr. ... very effective way to treat obstructive sleep apnea. Dr. Jamali is proud to offer this ... procedure that involves one or both jaw bones. This surgery is performed to correct the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market ... funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... and accelerate its technology and product roadmap. , “Jvion is experiencing ...
(Date:4/29/2016)... ... 2016 , ... CURE Media Group , the nation’s ... today announced that Lynne Malestic, RN, of Eisenhower Lucy Curci Cancer Center in ... Oncology Nursing , which honors nurses who have dedicated their careers to helping ...
Breaking Medicine News(10 mins):